Studies on 2(1H)-Quinolinone Derivatives as Gastric Antiulcer Active Agents. 2-(4-Chlorobenzoylamino)-3-[2(1H)-quinolinon-4-yl]propionic Acid and Related Compounds

Chemical and Pharmaceutical Bulletin

Volumn 33, Issue 9, 1985, Pages 3775-3786

  Uchida, Minoru ^a   Tabusa, Fujio ^a   Komatsu, Makoto ^a   Morita, Seiji ^a   Kanbe, Toshimi ^a   Nakagawa, Kazuyuki ^a  

^a OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

2 (4 chlorobenzoylamino) 3 2(1H) quinolinon 4 yl propionic acid; 2 acylamino 2(1H) quinolinonyl alkanoic acid; 2 amino 3 2(1H) quinolinon 4 yl propionic acid; antiulcer activity; cytoprotective effect; structure activity relationship

Indexed keywords

ACETIC ACID; CARBOSTYRIL DERIVATIVE; CIMETIDINE; NEW DRUG; REBAMIPIDE; SUCRALFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG ANALYSIS; DRUG COMPARISON; DRUG EFFICACY; DRUG IDENTIFICATION; DRUG SCREENING; DRUG SYNTHESIS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; STOMACH; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTI-ULCER AGENTS; CHEMISTRY; CHLOROBENZOATES; QUINOLINES; RATS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0022368275     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.33.3775     Document Type: Article

References (18)

1. S. Okabe, K. Takeuchi, K. Nakamura and K. Takagi, J. Pharm. Pharmacol., 26, 605 (1974);
2. Y. Suzuki, M. Ito and Y. Sudo, Jpn. J. Pharmacol., 29, 829 (1979).
3. Y. Suzuki, M. Hayashi, M. Ito and I. Yamaguchi, Jpn. J. Pharmacol., 26, 471 (1976).
4. W. F. Hahne, R. T. Jensen, G. F. Lemp and J. D. Gardner, Proc. Natl. Acad. Sci. U.S.A., 78, 6304 (1981);
5. R. Magous and J.-P. Bali, Eur. J. Pharmacol., 82, 47 (1982);
6. R. T. Jensen, S. W. Jones and J. D. Gardner, Biochim. Biophys. Acta, 761, 269 (1983).
7. K. Nakagawa, N. Murakami, S. Yoshizaki, M. Tominaga, H. Mori, Y. Yabuuchi and S. Shintani, J. Med. Chem., 17, 529 (1974).
8. S. Yoshizaki, K. Tanimura, S. Tamada, Y. Yabuuchi and K. Nakagawa, J. Med. Chem., 19, 1138 (1976).
9. T. Shimizu and M. Ishikawa, unpublished results.
10. K. Takagi, S. Okabe and R. Saziki, Jpn. J. Pharmacol., 19, 418 (1969);
11. S. Okabe and C. J. Pfeiffer, Digestive Diseases, 17, 619 (1972).
12. K. Yamasaki, T. Kanbe, H. Ishiyama and S. Morita, Abstracts of Papers, IUPHAR 9th International Congress of Pharmacology, 1984, p. 695;
13. T. Kanbe, K. Yamasaki, H. Ishiyama and S. Morita, Abstracts of Papers, IUPHAR 9th International Congress of Pharmacology, 1984, p. 696.
14. O. Meth-Cohn, S. Rhouati, B. Tarnowski and A. Robinson, J. Chem. Soc., Perkin Trans. 1, 1981, 1537.
15. E. Besthorn and E. Garben, Chem. Ber., 33, 3439 (1900).
16. S. Yoshizaki, S. Tamada and E. Yo, Chem. Pharm. Bull., 26, 2267 (1978).
17. M. Tominaga, E. Yo, H. Ogawa and K. Nakagawa, Japan. Patent 56–181360 (1981).
18. M. Hasegawa, Chem. Pharm. Bull., 1, 50 (1953).